Skip to search formSkip to main contentSkip to account menu

CRL 1005

Known as: CRL-1005 
A nonionic block copolymer adjuvant used to enhance viral or non-viral polynucleotide delivery in gene therapy vaccines.
National Institutes of Health

Related topics

Related topics

2 relations
CRL 1005/gp100 antigen/Montanide ISA-51/tyrosinase peptide

Broader (1)

Polymers

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
Systematic development of a block copolymer adjuvant for trivalent influenza virus vaccine.
The current influenza virus vaccines induce systemic humoral immunity and short lived cellular immunity in young adults… 
1997
1997
Effects of a beta-human chorionic gonadotropin subunit immunogen administered in aqueous solution with a novel nonionic block copolymer adjuvant in patients with advanced cancer.
The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)